Canadian study OKs Losec and Nexium

Feb 27, 2008

Health Canada has completed a review of safety information for Losec (omeprazole) and Nexium (esomeprazole) and found no increased cardiovascular risks.

Both prescription drugs are used to treat conditions in which a reduction of gastric acid secretion is required, such as ulcers and reflux.

In Canada, omeprazole is also sold in generic form as Apo-omeprazole, Ratio-omeprazole and Sandoz-omeprazole. Esomeprazole is only sold under the trade name Nexium.

Based on its review, Health Canada scientists said they found no evidence supporting an increased cardiovascular risk associated with the long-term use of either drug.

Officials advised patients taking either Losec or Nexium to not make any changes to their medication unless they first discuss it with their physicians.

Copyright 2008 by United Press International

Explore further: Police seize millions in huge fake Viagra swoop

add to favorites email to friend print save as pdf

Related Stories

Giant garbage patches help redefine ocean boundaries

24 minutes ago

The Great Pacific Garbage Patch is an area of environmental concern between Hawaii and California where the ocean surface is marred by scattered pieces of plastic, which outweigh plankton in that part of ...

New method for non-invasive prostate cancer screening

24 minutes ago

Cancer screening is a critical approach for preventing cancer deaths because cases caught early are often more treatable. But while there are already existing ways to screen for different types of cancer, ...

Clean air halves health costs in Chinese city

1 hour ago

Air pollution regulations over the last decade in Taiyuan, China, have substantially improved the health of people living there, accounting for a greater than 50% reduction in costs associated with loss of life and disability ...

Recommended for you

Mirabegron for overactive bladder: Added benefit not proven

1 hour ago

Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products ...

Novartis Japan admits concealing drug side effects

Sep 01, 2014

The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.

Most US babies get their vaccines, CDC says

Aug 28, 2014

(HealthDay)—The vast majority of American babies are getting the vaccines they need to protect them from serious illnesses, federal health officials said Thursday.

User comments : 0